Mylan, Inc. (Nasdaq: MYL) today announced that Zyomyx's MyT4™ point-of-care CD4 diagnostic test has received the CE Certificate of Conformity in the European Union, an important step toward launching this innovative test and expanding ...
Tags: Mylan, Zyomyx's MyT4™point-of-care CD4, diagnostic test, HIV
Those with HIV are living normal lifespans and their doctors should aim on preventive care for heart disease, diabetes and osteoporosis, U.S. researchers say. The Human Immunodeficiency Medicine Association of the Infectious Diseases ...
Tags: HIV, heart diease, HIV-infected, diabete, cancer
BNY Mellon, the global leader in investment management and investment services, has launched a global initiative to raise awareness of issues related to food security and waste through a series of nearly 100 employee volunteer events that ...
Tags: BNY Mellon, Food Security
The US Food and Drug Administration (FDA) has approved the first rapid point-of-care test that detects both HIV-1/2 antibodies and the HIV-1 antigen in human serum, plasma, and venous or fingerstick whole blood specimens. The Alere ...
Tags: Rapid Diagnostic Test, HIV-1, HIV-2
The European Commission has approved Gilead Sciences' Stribild for marketing as the single tablet regimen for HIV-1 treatment in all 27 countries of the European Union. Four of the Gilead's compounds elvitegravir 150mg, cobicistat 150mg, ...
Walgreens and the US Department of Health and Human Services (HHS) will colloborate to develop medication therapy management (MTM) program to improve outcomes for HIV patients. The multi-year program will study the impact of MTM ...